Citation: Rm. Neems et al., LIFETIME REPRODUCTIVE SUCCESS IN A SWARMING MIDGE - TRADE-OFFS AND STABILIZING SELECTION FOR MALE BODY-SIZE, Behavioral ecology, 9(3), 1998, pp. 279-286
Citation: Aj. Mclachlan et Se. Tett, EFFECT OF METABOLIC-INHIBITORS ON CYCLOSPORINE PHARMACOKINETICS USINGA POPULATION APPROACH, Therapeutic drug monitoring, 20(4), 1998, pp. 390-395
Authors:
WILLIAMS KM
MCLACHLAN AJ
PRITCHARD A
DAY RO
Citation: Km. Williams et al., COMPARATIVE PHARMACOKINETICS OF HEPATITIS-B IMMUNOGLOBULIN PRODUCTS AFTER INTRAMUSCULAR ADMINISTRATION IN HEALTHY-SUBJECTS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4212-4212
Authors:
SCHEUERER S
WILLIAMS KM
BRUGGER R
MCLACHLAN AJ
BRUNE K
DAY RO
GEISSLINGER G
Citation: S. Scheuerer et al., EFFECT OF CLOFIBRATE ON THE CHIRAL DISPOSITION OF IBUPROFEN IN RATS, The Journal of pharmacology and experimental therapeutics, 284(3), 1998, pp. 1132-1138
Citation: Ro. Day et al., POPULATION PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF TENOXICAM (TN) IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 125-125
Citation: Aj. Mclachlan, SIZE OR SYMMETRY - AN EXPERIMENT TO DETERMINE WHICH OF THE 2 ACCOUNTSFOR MATING SUCCESS IN MALE MIDGES, Ecoscience, 4(4), 1997, pp. 454-459
Authors:
AKHLAGHI F
MCLACHLAN AJ
KEOGH AM
BROWN KF
Citation: F. Akhlaghi et al., EFFECT OF SIMVASTATIN ON CYCLOSPORINE UNBOUND FRACTION AND APPARENT BLOOD CLEARANCE IN HEART-TRANSPLANT RECIPIENTS, British journal of clinical pharmacology, 44(6), 1997, pp. 537-542
Authors:
MCINTOSH DP
COOKE RJ
MCLACHLAN AJ
DALEYYATES PT
ROWLAND M
Citation: Dp. Mcintosh et al., PHARMACOKINETICS AND TISSUE DISTRIBUTION OF CISPLATIN AND CONJUGATES OF CISPLATIN WITH CARBOXYMETHYLDEXTRAN AND A5B7 MONOCLONAL-ANTIBODY INCD1 MICE, Journal of pharmaceutical sciences, 86(12), 1997, pp. 1478-1483
Citation: Aj. Mclachlan et Rm. Neems, FLIGHT ARCHITECTURE DETERMINED BY PHYSICAL CONSTRAINTS OR BY NATURAL-SELECTION - THE CASE OF THE MIDGE CHIRONOMUS-PLUMOSUS, Journal of zoology, 240, 1996, pp. 301-308
Citation: Aj. Mclachlan et Se. Tett, PHARMACOKINETICS OF FLUCONAZOLE IN PEOPLE WITH HIV-INFECTION - A POPULATION ANALYSIS, British journal of clinical pharmacology, 41(4), 1996, pp. 291-298
Authors:
GRAHAM S
DAY RO
WONG H
MCLACHLAN AJ
BERGENDAL L
MINERS JO
BIRKETT DJ
Citation: S. Graham et al., PHARMACODYNAMICS OF OXYPURINOL AFTER ADMINISTRATION OF ALLOPURINOL TOHEALTHY-SUBJECTS, British journal of clinical pharmacology, 41(4), 1996, pp. 299-304
Citation: Aj. Mclachlan et Se. Tett, ENANTIOSELECTIVE DISPOSITION OF HYDROXYCHLOROQUINE, British journal of clinical pharmacology, 41(4), 1996, pp. 347-347
Citation: Aj. Mclachlan, SPARSE DRUG CONCENTRATION DATA-ANALYSIS USING A POPULATION APPROACH -A VALUABLE TOOL IN CLINICAL-PHARMACOLOGY, Clinical and experimental pharmacology and physiology, 23(10-11), 1996, pp. 995-999
Citation: Aj. Mclachlan et Km. Williams, ESTIMATION OF THE RATE AND EXTENT OF CHIRAL INVERSION USING LINEAR-SYSTEMS ANALYSIS, Chirality, 7(8), 1995, pp. 632-635
Citation: Ch. Chou et al., MEMBRANE-PERMEABILITY AND LIPOPHILICITY IN THE ISOLATED-PERFUSED RAT-LIVER - 5-ETHYL BARBITURIC-ACID AND OTHER COMPOUNDS, The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 933-940
Citation: Se. Tett et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF HYDROXYCHLOROQUINE ENANTIOMERS IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING MULTIPLE DOSES OF RACEMATE, Chirality, 6(4), 1994, pp. 355-359
Citation: Aj. Mclachlan et al., DISPOSITION AND ABSORPTION OF HYDROXYCHLOROQUINE ENANTIOMERS FOLLOWING A SINGLE-DOSE OF THE RACEMATE, Chirality, 6(4), 1994, pp. 360-364
Citation: Z. Hussein et al., DISTRIBUTION KINETICS OF SALICYLIC-ACID IN THE ISOLATED-PERFUSED RAT-LIVER ASSESSED USING MOMENT ANALYSIS AND THE 2-COMPARTMENT AXIAL-DISPERSION MODEL, Pharmaceutical research, 11(9), 1994, pp. 1337-1345
Authors:
CHAN E
MCLACHLAN AJ
PEGG M
MACKAY AD
COLE RB
ROWLAND M
Citation: E. Chan et al., DISPOSITION OF WARFARIN ENANTIOMERS AND METABOLITES IN PATIENTS DURING MULTIPLE DOSING WITH RAC-WARFARIN, British journal of clinical pharmacology, 37(6), 1994, pp. 563-569
Citation: Aj. Mclachlan et al., BIOAVAILABILITY OF HYDROXYCHLOROQUINE TABLETS IN PATIENTS WITH RHEUMATOID-ARTHRITIS, British journal of rheumatology, 33(3), 1994, pp. 235-239
Citation: E. Chan et al., WARFARIN METABOLITES - STEREOCHEMICAL ASPECTS OF PROTEIN-BINDING AND DISPLACEMENT BY PHENYLBUTAZONE, Chirality, 5(8), 1993, pp. 610-615
Citation: Aj. Mclachlan et al., ABSORPTION AND IN-VIVO DISSOLUTION OF HYDROXYCHOLOROQUINE IN FED SUBJECTS ASSESSED USING DECONVOLUTION TECHNIQUES, British journal of clinical pharmacology, 36(5), 1993, pp. 405-411
Citation: Aj. Mclachlan et al., DISPOSITION OF THE ENANTIOMERS OF HYDROXYCHLOROQUINE IN PATIENTS WITHRHEUMATOID-ARTHRITIS FOLLOWING MULTIPLE DOSES OF THE RACEMATE, British journal of clinical pharmacology, 36(1), 1993, pp. 78-81